The Gatekeepers of Biology: Transporters as Drug Targets (Volume 70)
For a century, pharmacologists were obsessed with “receptors”—the locks on the outside of a cell. But what happens when the drug needs to get inside the cell, or when the cell is actively trying to throw a toxic drug back out? Transporters as Drug Targets (Volume 70 in the Advances in Pharmacology series) is the definitive, fiercely advanced scientific monograph that forces a massive paradigm shift in drug discovery. For medicinal chemists, molecular biologists, and R&D executives, this volume provides the uncompromising blueprints for manipulating the microscopic pumps and tunnels that control human biology.
Shifting the Focus from Receptors to Transporters
The opening chapters of this book aggressively establish a new reality in pharmacology. The authors explain that the human body contains hundreds of different transporter proteins (like SLC and ABC families) whose sole job is to move chemicals across cell membranes. The text rigorously details how targeting these specific pumps—rather than traditional receptors—opens up entirely new, highly lucrative avenues for treating devastating diseases.
Hijacking Cellular Uptake Mechanisms
The core of the monograph provides a masterclass in molecular biology. The authors exhaustively detail the physics of membrane transport. Readers will explore exactly how to design a drug that physically binds to an active transporter protein, forcing the protein to carry the drug across the blood-brain barrier or deep into the liver tissue, completely bypassing the normal rules of lipid solubility.
Inhibiting Reuptake: The Pharmacology of SSRIs and Cocaine
This is a fiercely detailed guide to neuropharmacology. The book tackles the most famous examples of transporter targeting: the brain’s neurotransmitter reuptake pumps. The authors provide the exact molecular physics of how Selective Serotonin Reuptake Inhibitors (SSRIs) physically jam the serotonin transporter (SERT), causing serotonin to flood the synapse and reverse clinical depression. They also detail how cocaine violently blocks the dopamine transporter (DAT), causing massive addiction.
Overcoming Multi-Drug Resistance (MDR) Efflux Pumps
The book pushes into the most terrifying challenge in modern oncology: Multi-Drug Resistance (MDR). When you give a patient chemotherapy, the cancer cell often survives by building massive “Efflux Pumps” (like P-glycoprotein) that simply grab the chemo and throw it back into the blood. The authors provide the exact medicinal chemistry strategies required to design drugs that physically break or bypass these pumps, re-sensitizing the cancer cell to the poison.
The Next Generation of Targeted Therapeutics
The final chapters address the reality of the pharmaceutical pipeline. The authors provide rigorous breakdowns of the newest transporters being investigated for drug discovery, including the SGLT2 transporters in the kidney (the target of massive new diabetes drugs). They detail the complex, high-throughput screening techniques required to find novel chemicals that can turn these microscopic pumps on or off.
Frequently Asked Questions (FAQs)
Is this a textbook for medical students?
No. This is a highly advanced, deeply scientific volume intended for the absolute upper echelon of research. It requires a profound understanding of molecular biology, protein folding, and advanced pharmacodynamics.
Does it cover pharmacokinetics and drug-drug interactions?
Yes, massively. Transporters (especially in the liver and kidney) are the primary sites of dangerous drug-drug interactions, and this book details the exact molecular basis of those competitive blockades.
Who is the primary audience?
It is the absolute gold-standard reference for Ph.D. medicinal chemists, molecular biologists, and R&D scientists working in the biotechnology and pharmaceutical sectors.
Conclusion
Transporters as Drug Targets proves that mastering human biology requires controlling the gates. It is an indispensable guide to the absolute frontier of drug discovery. By mastering the physics of active transport, the manipulation of reuptake pumps, and the evasion of cancer efflux systems detailed in this volume, scientists can successfully design the next generation of revolutionary, highly targeted therapeutics.
